本文選題：導(dǎo)管消融術(shù)　切入點(diǎn)：心動(dòng)過速　出處：《重慶醫(yī)學(xué)》2017年22期 　論文類型：期刊論文

【摘要】：目的對(duì)比Ensite Velocity三維電解剖標(biāo)測(cè)系統(tǒng)零X線曝光與常規(guī)X線曝光下行導(dǎo)管射頻消融術(shù)(RFCA)治療陣發(fā)性室上性心動(dòng)過速(PSVT)的療效及安全性。方法利用選取法選取該院2014-2016年100例行RFCA治療的PSVT患者,并將其分為對(duì)照組(常規(guī)X線曝光)和觀察組(三維電解剖標(biāo)測(cè)系統(tǒng)零X線曝光),各50例,分析兩組手術(shù)時(shí)間、X線曝光時(shí)間、并發(fā)癥率、即時(shí)和隨訪成功率。結(jié)果兩組手術(shù)時(shí)間差異無統(tǒng)計(jì)學(xué)意義(P0.05),但觀察組X線曝光時(shí)間[(0.46±0.14)min]較對(duì)照組[(13.87±4.03)min]明顯下降,并發(fā)癥率(0)亦明顯低于對(duì)照組(8.00%);即時(shí)成功率(98.00%)明顯高于對(duì)照組(84.00%),隨訪成功率(94.00%)亦遠(yuǎn)遠(yuǎn)高于對(duì)照組(74.00%),差異均有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論運(yùn)用Ensite Velocity三維電解剖標(biāo)測(cè)系統(tǒng)在行RFCA治療PSVT的臨床療效較理想,且安全可靠。
[Abstract]:Objective to compare the efficacy and safety of radiofrequency catheter ablation (RFCA) in the treatment of paroxysmal supraventricular tachycardia with Ensite Velocity three-dimensional electroanatomic mapping system with zero X-ray exposure and conventional X-ray exposure. 100 PSVT patients who were treated with RFCA, They were divided into two groups: the control group (conventional X-ray exposure) and the observation group (three dimensional electroanatomy mapping system with zero X-ray exposure, 50 cases each). The time of operation and the rate of complications were analyzed. Results there was no significant difference in the operation time between the two groups (P 0.05), but the X-ray exposure time in the observation group [0.46 鹵0.14 min] was significantly lower than that in the control group [13.87 鹵4.03 min]. The complication rate was also significantly lower than that in the control group (8.00%), and the immediate success rate was 98.00) significantly higher than that in the control group (84.00%) and the follow-up rate was 94.00% (P < 0.05). Conclusion the application of Ensite Velocity three-dimensional electroanatomy mapping system is in operation, and is much higher than that in the control group (74.00%). The clinical efficacy of RFCA in the treatment of PSVT is ideal. And safe and reliable.
【作者單位】： 河北醫(yī)科大學(xué)第一醫(yī)院心內(nèi)科;河北醫(yī)科大學(xué)第一醫(yī)院心外科;河北醫(yī)科大學(xué)第一醫(yī)院消化內(nèi)科;
【基金】：國(guó)家自然科學(xué)基金資助項(xiàng)目(H0212) 河北省衛(wèi)生廳課題項(xiàng)目(20160681、1020140453)
【分類號(hào)】：R541.71
，

本文編號(hào)：1590724